These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32839463)

  • 21. Association of Wnt signaling pathway genetic variants in gallbladder cancer susceptibility and survival.
    Yadav A; Gupta A; Yadav S; Rastogi N; Agrawal S; Kumar A; Kumar V; Misra S; Mittal B
    Tumour Biol; 2016 Jun; 37(6):8083-95. PubMed ID: 26715268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracholecystic Papillary Neoplasms Are Distinct From Papillary Gallbladder Cancers: A Clinicopathologic and Exome-sequencing Study.
    Akita M; Fujikura K; Ajiki T; Fukumoto T; Otani K; Hirose T; Tominaga M; Itoh T; Zen Y
    Am J Surg Pathol; 2019 Jun; 43(6):783-791. PubMed ID: 30807303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial-specific ETS-1 (ESE1/ELF3) regulates apoptosis of intestinal epithelial cells in ulcerative colitis via accelerating NF-κB activation.
    Li L; Miao X; Ni R; Miao X; Wang L; Gu X; Yan L; Tang Q; Zhang D
    Immunol Res; 2015 Jun; 62(2):198-212. PubMed ID: 25926267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ELF3 promotes epithelial-mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma.
    Zheng L; Xu M; Xu J; Wu K; Fang Q; Liang Y; Zhou S; Cen D; Ji L; Han W; Cai X
    Cell Death Dis; 2018 Mar; 9(3):387. PubMed ID: 29523781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Landscape of genomic alterations in cervical carcinomas.
    Ojesina AI; Lichtenstein L; Freeman SS; Pedamallu CS; Imaz-Rosshandler I; Pugh TJ; Cherniack AD; Ambrogio L; Cibulskis K; Bertelsen B; Romero-Cordoba S; Treviño V; Vazquez-Santillan K; Guadarrama AS; Wright AA; Rosenberg MW; Duke F; Kaplan B; Wang R; Nickerson E; Walline HM; Lawrence MS; Stewart C; Carter SL; McKenna A; Rodriguez-Sanchez IP; Espinosa-Castilla M; Woie K; Bjorge L; Wik E; Halle MK; Hoivik EA; Krakstad C; Gabiño NB; Gómez-Macías GS; Valdez-Chapa LD; Garza-Rodríguez ML; Maytorena G; Vazquez J; Rodea C; Cravioto A; Cortes ML; Greulich H; Crum CP; Neuberg DS; Hidalgo-Miranda A; Escareno CR; Akslen LA; Carey TE; Vintermyr OK; Gabriel SB; Barrera-Saldaña HA; Melendez-Zajgla J; Getz G; Salvesen HB; Meyerson M
    Nature; 2014 Feb; 506(7488):371-5. PubMed ID: 24390348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of p53 gene in gallbladder cancer patients of North India.
    Nigam P; Misra U; Negi TS; Mittal B; Choudhuri G
    Trop Gastroenterol; 2010; 31(2):96-100. PubMed ID: 20862982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC.
    Arolt C; Dugan M; Wild R; Richartz V; Holz B; Scheel AH; Brägelmann J; Wagener-Ryczek S; Merkelbach-Bruse S; Wolf J; Buettner R; Catanzariti L; Scheffler M; Hillmer AM
    J Thorac Oncol; 2023 Nov; 18(11):1550-1567. PubMed ID: 37473958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenome-Wide Analysis of Methylation Changes in the Sequence of Gallstone Disease, Dysplasia, and Gallbladder Cancer.
    Brägelmann J; Barahona Ponce C; Marcelain K; Roessler S; Goeppert B; Gallegos I; Colombo A; Sanhueza V; Morales E; Rivera MT; de Toro G; Ortega A; Müller B; Gabler F; Scherer D; Waldenberger M; Reischl E; Boekstegers F; Garate-Calderon V; Umu SU; Rounge TB; Popanda O; Lorenzo Bermejo J
    Hepatology; 2021 Jun; 73(6):2293-2310. PubMed ID: 33020926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The function of the ELF3 gene and its mechanism in cancers.
    Ju Y; Fang S; Liu L; Ma H; Zheng L
    Life Sci; 2024 Jun; 346():122637. PubMed ID: 38614305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E74-Like Factor (ELF3) and Leptin, a Novel Loop Between Obesity and Inflammation Perpetuating a Pro-Catabolic State in Cartilage.
    Conde J; Otero M; Scotece M; Abella V; Gómez R; López V; Pino J; Mera A; Goldring MB; Gualillo O
    Cell Physiol Biochem; 2018; 45(6):2401-2410. PubMed ID: 29550824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas.
    Jin X; Zheng Y; Chen Z; Wang F; Bi G; Li M; Liang J; Sui Q; Bian Y; Hu Z; Qiao Y; Xu S
    Cancer Med; 2021 Dec; 10(23):8673-8692. PubMed ID: 34617407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ELF3 activated by a superenhancer and an autoregulatory feedback loop is required for high-level HLA-C expression on extravillous trophoblasts.
    Li Q; Meissner TB; Wang F; Du Z; Ma S; Kshirsagar S; Tilburgs T; Buenrostro JD; Uesugi M; Strominger JL
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33622787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes.
    Mesquita B; Lopes P; Rodrigues A; Pereira D; Afonso M; Leal C; Henrique R; Lind GE; Jerónimo C; Lothe RA; Teixeira MR
    Breast Cancer Res Treat; 2013 Feb; 138(1):37-45. PubMed ID: 23329352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FZD5 prevents epithelial-mesenchymal transition in gastric cancer.
    Dong D; Na L; Zhou K; Wang Z; Sun Y; Zheng Q; Gao J; Zhao C; Wang W
    Cell Commun Signal; 2021 Feb; 19(1):21. PubMed ID: 33618713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer.
    Wang H; Yu Z; Huo S; Chen Z; Ou Z; Mai J; Ding S; Zhang J
    Int J Biochem Cell Biol; 2018 Jan; 94():98-106. PubMed ID: 29208568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.
    Gingras MC; Covington KR; Chang DK; Donehower LA; Gill AJ; Ittmann MM; Creighton CJ; Johns AL; Shinbrot E; Dewal N; Fisher WE; ; Pilarsky C; Grützmann R; Overman MJ; Jamieson NB; Van Buren G; Drummond J; Walker K; Hampton OA; Xi L; Muzny DM; Doddapaneni H; Lee SL; Bellair M; Hu J; Han Y; Dinh HH; Dahdouli M; Samra JS; Bailey P; Waddell N; Pearson JV; Harliwong I; Wang H; Aust D; Oien KA; Hruban RH; Hodges SE; McElhany A; Saengboonmee C; Duthie FR; Grimmond SM; Biankin AV; Wheeler DA; Gibbs RA
    Cell Rep; 2016 Feb; 14(4):907-919. PubMed ID: 26804919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress and deregulations in base excision repair pathway as contributors to gallbladder anomalies and carcinoma - a study involving North-East Indian population.
    Singh N; Kazim SN; Sultana R; Tiwari D; Borkotoky R; Kakati S; Nath Das N; Kumar Saikia A; Bose S
    Free Radic Res; 2019 May; 53(5):473-485. PubMed ID: 31117842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic profiling of gallbladder carcinoma: Targetable mutations and pathways involved.
    Mishra S; Kumari S; Srivastava P; Pandey A; Shukla S; Husain N
    Pathol Res Pract; 2022 Apr; 232():153806. PubMed ID: 35231860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCί.
    Lee JS; Choi YE; Kim S; Han JY; Goh SH
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma.
    Yachida S; Wood LD; Suzuki M; Takai E; Totoki Y; Kato M; Luchini C; Arai Y; Nakamura H; Hama N; Elzawahry A; Hosoda F; Shirota T; Morimoto N; Hori K; Funazaki J; Tanaka H; Morizane C; Okusaka T; Nara S; Shimada K; Hiraoka N; Taniguchi H; Higuchi R; Oshima M; Okano K; Hirono S; Mizuma M; Arihiro K; Yamamoto M; Unno M; Yamaue H; Weiss MJ; Wolfgang CL; Furukawa T; Nakagama H; Vogelstein B; Kiyono T; Hruban RH; Shibata T
    Cancer Cell; 2016 Feb; 29(2):229-40. PubMed ID: 26806338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.